These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22751085)

  • 1. Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease.
    Nishikawa N; Nagai M; Tsujii T; Iwaki H; Yabe H; Nomoto M
    Clin Neuropharmacol; 2012; 35(4):182-4. PubMed ID: 22751085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
    Muhlack S; Woitalla D; Welnic J; Twiehaus S; Przuntek H; Müller T
    Neurosci Lett; 2004 Jun; 363(3):284-7. PubMed ID: 15182961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of levodopa with carbidopa, and levodopa with domperidone in Parkinson's disease.
    Langdon N; Malcolm PN; Parkes JD
    Clin Neuropharmacol; 1986; 9(5):440-7. PubMed ID: 3768866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative study of salivary secretion in Parkinson's disease.
    Tumilasci OR; Cersósimo MG; Belforte JE; Micheli FE; Benarroch EE; Pazo JH
    Mov Disord; 2006 May; 21(5):660-7. PubMed ID: 16419045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease.
    Contin M; Martinelli P; Scaglione C; Avoni P; Albani F; Riva R; Baruzzi A
    Clin Neuropharmacol; 2008; 31(5):267-71. PubMed ID: 18836344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domperidone and levodopa in Parkinson's disease.
    Shindler JS; Finnerty GT; Towlson K; Dolan AL; Davies CL; Parkes JD
    Br J Clin Pharmacol; 1984 Dec; 18(6):959-62. PubMed ID: 6529536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
    Baas H; Harder S; Bürklin F; Demisch L; Fischer PA
    Clin Neuropharmacol; 1998; 21(2):86-92. PubMed ID: 9579293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DA-9701 on gastric motility in patients with Parkinson's disease: A randomized controlled trial.
    Shin CM; Lee YJ; Kim JM; Lee JY; Kim KJ; Choi YJ; Kim N; Lee DH
    Parkinsonism Relat Disord; 2018 Sep; 54():84-89. PubMed ID: 29705555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease].
    Nomoto M; Nakatsuka A; Nagai M; Yabe H; Moritoyo T; Moritoyo H; Nisikawa N
    Rinsho Shinkeigaku; 2005 Nov; 45(11):895-8. PubMed ID: 16447756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
    Stocchi F; Vacca L; Ruggieri S; Olanow CW
    Arch Neurol; 2005 Jun; 62(6):905-10. PubMed ID: 15956161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute levodopa intake and associated cortisol decrease in patients with Parkinson disease.
    Müller T; Muhlack S
    Clin Neuropharmacol; 2007; 30(2):101-6. PubMed ID: 17414942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
    Hauser RA; Ellenbogen AL; Metman LV; Hsu A; O'Connell MJ; Modi NB; Yao HM; Kell SH; Gupta SK
    Mov Disord; 2011 Oct; 26(12):2246-52. PubMed ID: 21755537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
    Metman LV; Blanchet PJ; de Jong D; Mouradian MM; Chase TN
    Mov Disord; 1996 May; 11(3):257-60. PubMed ID: 8723141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease. Parkinson Study Group.
    Clin Neuropharmacol; 1999; 22(4):220-5. PubMed ID: 10442252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.
    Simon N; Gantcheva R; Bruguerolle B; Viallet F
    Parkinsonism Relat Disord; 2004 Mar; 10(3):137-42. PubMed ID: 15036167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of gastroretentive delivery of levodopa/carbidopa in patients with Parkinson disease.
    Chen C; Cowles VE; Sweeney M; Stolyarov ID; Illarioshkin SN
    Clin Neuropharmacol; 2012; 35(2):67-72. PubMed ID: 22377973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
    Müller T; Kuhn W
    Mov Disord; 2009 Jul; 24(9):1339-43. PubMed ID: 19425084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.